Effect of processing delay and storage conditions on urine albumin-to-creatinine ratio

Effect of processing delay and storage conditions on urine albumin-to-creatinine ratio

<h4>Background and objectives</h4> <p>Because there is substantial biologic intraindividual variation in albumin excretion, randomized trials of albuminuria-reducing therapies may need multiple urine samples to estimate daily urinary albumin excretion. Mailing spot urine samples c...

Bibliográfalaš dieđut
Váldodahkkit:	Herrington, W, Illingworth, N, Staplin, N, Kumar, A, Storey, B, Hrusecka, R, Judge, P, Parish, S, Landray, M, Haynes, R, Baigent, C, Hill, M, Clark, S
Materiálatiipa:	Journal article
Almmustuhtton:	American Society for Nephrology 2016

Geahča maid

KORELASI ANTARA KADAR PLASMA ENDOTELIN-1 DENGAN ALBUMIN CREATININ RATIO URIN PADA WANITA DIABETES MELITUS TIPE 2
Dahkki: , dr. Rusdiana, et al.
Almmustuhtton: (2013)

Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes
Dahkki: Rossing, P, et al.
Almmustuhtton: (2023)

Use of gel-based separator tubes to stabilise phosphate in mailed blood samples.
Dahkki: Herrington, W, et al.
Almmustuhtton: (2015)

Comparasion of Sport Urine Protein Creatinine From Three Different Time Urine Samples in Children With Primary Nephrotic
Dahkki: Perpustakaan UGM, i-lib
Almmustuhtton: (2007)

Perbandingan kadar albumin, proteintotal, urea, asam urat darah dan rasio urea/kreatinin urin sebelum dan sewaktu puasa ramadhan = Comparation of Blood Albumin, Total Protein, Uric Acid and Urinary Urea/Creatinin ...
Dahkki: Perpustakaan UGM, i-lib
Almmustuhtton: (2001)

Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
Dahkki: Haynes, R, et al.
Almmustuhtton: (2018)

Renal and cardiovascular risk according to tertiles of urinary albumin-to-creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
Dahkki: Marcovecchio, M, et al.
Almmustuhtton: (2018)

Evidence for the prevention and treatment of stroke in dialysis patients
Dahkki: Herrington, W, et al.
Almmustuhtton: (2014)

Use of causal diagrams to inform the analysis and interpretation of observational studies: An example from the Study of Heart and Renal Protection (SHARP)
Dahkki: Staplin, N, et al.
Almmustuhtton: (2016)

Limitations of the microalbumin/creatinine ratio in detecting early microalbuminuria in type 1 diabetes
Dahkki: Karunakaran, S, et al.
Almmustuhtton: (1999)

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
Dahkki: Mafham, M, et al.
Almmustuhtton: (2017)

Conventional and genetic evidence on the association between adiposity and chronic kidney disease
Dahkki: Zhu, P, et al.
Almmustuhtton: (2020)

Impact of diabetes on the effects of sodium glucose co-transporter-2 (SGLT2) inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
Dahkki: Herrington, W, et al.
Almmustuhtton: (2022)

Biliary tract and liver complications in polycystic kidney disease
Dahkki: Judge, P, et al.
Almmustuhtton: (2017)

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy
Dahkki: Storey, B, et al.
Almmustuhtton: (2018)

Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease
Dahkki: Zhu, D, et al.
Almmustuhtton: (2025)

Urinary lactate :: Creatinine ratio as diagnostic test for hypoxic-ischemic encephalopathy in neonates with asphyxia
Dahkki: , HANUM P., Syarifah, et al.
Almmustuhtton: (2003)

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank
Dahkki: Zhu, P, et al.
Almmustuhtton: (2020)

Kidney disease trials for the 21st century: innovations in design and conduct
Dahkki: Herrington, W, et al.
Almmustuhtton: (2019)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Dahkki: Storey, B, et al.
Almmustuhtton: (2017)

Neprilysin inhibition in chronic kidney disease.
Dahkki: Judge, P, et al.
Almmustuhtton: (2014)

Conventional and genetic evidence on the association between adiposity and CKD
Dahkki: Zhu, P, et al.
Almmustuhtton: (2020)

The authors reply
Dahkki: Chapman, D, et al.
Almmustuhtton: (2023)

Fibroblast growth factor-23 and risk of cardiovascular diseases: a Mendelian randomization study
Dahkki: Donovan, K, et al.
Almmustuhtton: (2022)

Molecularly Imprinted Silica Matrix In Detection Of Creatinine
Dahkki: Florence, Chan
Almmustuhtton: (2017)

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial
Dahkki: Mayne, KM, et al.
Almmustuhtton: (2024)

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial
Dahkki: Mayne, K, et al.
Almmustuhtton: (2024)

Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data
Dahkki: Harper, C, et al.
Almmustuhtton: (2023)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
Dahkki: Harper, C, et al.
Almmustuhtton: (2021)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
Dahkki: Harper, C, et al.
Almmustuhtton: (2021)

A NEUTRON REFLECTIVITY STUDY OF A SPREAD MONOLAYER OF BOVINE SERUM-ALBUMIN
Dahkki: Eaglesham, A, et al.
Almmustuhtton: (1992)

Korelasi kadar interferon-gamma serum dengan rasio albumin atau kreatinin urin pada penderita hipertensi esensial
Dahkki: , SARI, Lisa Kurnia, et al.
Almmustuhtton: (2010)

Accelerometer-measured physical activity and functional behaviours among people on dialysis
Dahkki: Nawab, KA, et al.
Almmustuhtton: (2020)

Serum creatinine and fat-free mass (lean body mass).
Dahkki: Swaminathan, R, et al.
Almmustuhtton: (2000)

Interleukin-6-to-albumin ratio for mortality prediction in critically ill elderly patients
Dahkki: Yang, Lim Kai
Almmustuhtton: (2024)

Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease
Dahkki: Mayne, K, et al.
Almmustuhtton: (2023)

Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD
Dahkki: Lamprea-Montealegre, J, et al.
Almmustuhtton: (2019)

Relationship between dietary protein intake and serum urea, uric acid and creatinine, and 24-hour urinary creatinine excretion: the BIRNH study /
Dahkki: 199370 Kesteloot, Hugo E., et al.

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
Dahkki: Herrington, W, et al.
Almmustuhtton: (2018)

Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
Dahkki: Herrington, WG, et al.
Almmustuhtton: (2023)